Fig. 8.
Sequence of the major form of the ERVWE1 envelope polypeptide derived from 24 individuals. The leader peptide (L), the surface protein (SU), the furine cleavage site (bold letters), the transmembrane protein (TM), the hydrophobic fusion peptide (lowercase letters, underlined), the immunosuppressive region (lowercase letter), the carboxy-transmembrane region (underlined), and potential glycosylation sites (dots) are indicated.